Skip to main content
AVBP logo

AVBP · ArriVent BioPharma, Inc.

Track AVBP — free
$30.95 -0.08 (-0.26%) At close · Sep 4
Market Cap
$1.53B
Shares
49.31M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

AVBP Latest Reported Short Interest

FINRA reported 8,227,393 AVBP shares sold short as of the August 14, 2026 settlement date, an increase of 180,918 shares. Days to cover was 21.76 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

AVBP Short Interest Forecast

Equibles' model estimates 8,522,682 shares sold short for the August 31, 2026 settlement, +3.6% versus the latest reported position, with a likely range of 7,940,405 to 9,097,482 shares. This model prediction uses FINRA data through August 31, 2026; FINRA's official release is expected September 10, 2026.

Model estimate

Expected Aug 31 short interest

as of Aug 31 Low confidence 54% chance it rises
8,522,682 +3.6% vs reported
Likely range 7,940,405 to 9,097,482 The latest estimate appears in the chart below. Official release expected Sep 10. Methodology
Short Squeeze Score
68/100
Short interest 16.7% of shares — P97 Days to cover 21.8 — P96 Price vs VWAP -2.1% — P43 Short-volume trend -9.8% — P19 Short interest change +2.2% — P62 Worst FTD 0.01% of shares — P45

Peer-relative percentile rank across all listed securities reporting short interest at the latest settlement date (2026-08-14). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-09-15 Scheduled
FINRA publishes Sep 24
2026-08-31 Scheduled
FINRA publishes Sep 10
2026-08-14 8,227,393 8,046,475 +180,918 21.76
2026-07-31 8,046,475 7,665,375 +381,100 13.92
2026-07-15 7,665,375 7,624,281 +41,094 17.85
2026-06-30 7,624,281 7,847,671 -223,390 9.05
2026-06-15 7,847,671 7,709,676 +137,995 13.12
2026-05-29 7,709,676 7,299,894 +409,782 14.42
2026-05-15 7,299,894 7,109,751 +190,143 22.55
2026-04-30 7,109,751 7,666,061 -556,310 14.30
2026-04-15 7,666,061 7,763,960 -97,899 14.54
2026-03-31 7,763,960 7,228,395 +535,565 17.89
2026-03-13 7,228,395 7,003,796 +224,599 9.33
2026-02-27 7,003,796 7,046,765 -42,969 25.09
2026-02-13 7,046,765 7,216,603 -169,838 11.53
2026-01-30 7,216,603 7,178,615 +37,988 16.70
2026-01-15 7,178,615 6,985,261 +193,354 18.17
2025-12-31 6,985,261 6,747,370 +237,891 14.91
2025-12-15 6,747,370 7,262,061 -514,691 14.76
2025-11-28 7,262,061 7,169,047 +93,014 28.67
2025-11-14 7,169,047 6,927,026 +242,021 19.44
2025-10-31 6,927,026 7,063,874 -136,848 22.65
2025-10-15 7,063,874 6,783,254 +280,620 23.57
2025-09-30 6,783,254 6,594,695 +188,559 17.09
2025-09-15 6,594,695 6,797,763 -203,068 19.30

Full FINRA short interest reporting calendar

Showing 1–23 of 23 settlements
Key facts CIK 1868279 CUSIP 04272N102 13F (30d) 133 filings 133 filers Visit website Investor relations